Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Shifting gears: the search for group 3 pulmonary hypertension treatment
Jennifer L. Keen
,
Thenappan Thenappan
Pulmonary, Allergy, Critical Care and Sleep Medicine
Medicine - Cardiology Division
Lillehei Heart Institute
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Shifting gears: the search for group 3 pulmonary hypertension treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Group 3 Pulmonary Hypertension
100%
Pulmonary Hypertension Treatment
100%
Pulmonary Hypertension
75%
Right Ventricle
50%
Pulmonary Vasodilators
50%
Pulmonary Arterial Hypertension
25%
Improved Outcomes
25%
Patient Demographics
25%
Exertional
25%
Vasodilator
25%
Lung Transplantation
25%
Lung Disease
25%
Interstitial Lung Disease
25%
Putative Drug Targets
25%
Disease-associated
25%
High Mortality
25%
Chronic Hypoxia
25%
Holy Grail
25%
Pulmonary Vasculitis
25%
Therapeutic Interventions
25%
Intervention Targets
25%
Inhaled Treprostinil
25%
Medicine and Dentistry
Pulmonary Hypertension
100%
Right Ventricle
25%
Morbidity
25%
Peripheral Vasodilating Agent
25%
Interstitial Lung Disease
12%
Hemodynamic
12%
Hypoxia
12%
Patient Population
12%
Lung Transplantation
12%
Silo-Filler's Disease
12%
Pulmonary Vascular Disease
12%
Treprostinil
12%
Diseases
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Morbidity
25%
Peripheral Vasodilating Agent
25%
Lung Disease
12%
Hypoxia
12%
Pulmonary Vascular Disease
12%
Interstitial Lung Disease
12%
Treprostinil
12%
Diseases
12%